期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Assessment of the Visual Analogue Score in the Evaluation of the Pruritus of Cholestasis 被引量:17
1
作者 Nora V.Bergasa E.Anthony Jones 《Journal of Clinical and Translational Hepatology》 SCIE 2017年第3期203-207,共5页
Background and Aims:A visual analogue score (VAS),based on application of a visual analogue scale,has been widely used to assess pruritus in clinical studies of patients with cholestatic liver disease.A VAS is a numer... Background and Aims:A visual analogue score (VAS),based on application of a visual analogue scale,has been widely used to assess pruritus in clinical studies of patients with cholestatic liver disease.A VAS is a numerical score of the severity of the perception of pruritus,and,hence,is inherently subjective.The objective of this study was to assessthe reliability of a VAS as an index of pruritus in cholestatic patients.Methods:In 8 patients with chronic pruritus due to primary biliary cholangitis,values for a VAS of pruritus were compared with corresponding measurements of scratching activity,which were generated by a monitoring system specifically designed to quantitate this activity.The relationship between individual values for the VAS and corresponding values for scratching activity during a specific interval immediately preceding the recording of the VAS was examined by determining the Spearman's rank correlation coefficient.Results:The mean Spearman's rank correlation coefficient between individual values for the VAS and corresponding mean values for scratching activity was 0.072;the range of these coefficients was-0.04 to 0.26.A VAS of pruritus is an unreliable index of scratching activity,and,hence,of the pathophysiological process responsible for the pruritus of cholestasis.Conclusion:It is concluded that the use of a VAS as a primary quantitative endpoint in trials of the efficacy of potential therapies for the pruritus of cholestasis may be inappropriate. 展开更多
关键词 PRURITUS CHOLESTASIS Visual analogue score Scratching activity Primary biliary cholangitis quantitative efficacy endpoint
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部